Definition and epidemiology
Lobar pneumonia refers to a radiographic and pathologic pattern of pneumonia in which infection spreads through the alveoli of a contiguous lobe or large segment via the pores of Kohn and interalveolar connections, producing uniform, dense consolidation that respects lobar (fissural) boundaries. This contrasts with bronchopneumonia, which produces patchy, multifocal infiltrates centered on airways.
Lobar pneumonia is a subset of community-acquired pneumonia (CAP). It occurs across all ages but is more common in otherwise healthy adults and older children rather than infants, who more often develop bronchopneumonia. Incidence rises in winter months and in settings of overcrowding. Mortality and morbidity are higher in the elderly, in those with comorbidities, and in low-resource settings where access to antibiotics and vaccination is limited.
- CAP overall affects several million adults per year in the United States; a sizable minority show a lobar pattern.
- Pneumococcal vaccination has reduced invasive pneumococcal disease substantially since routine use in children and at-risk adults.
- Four classical stages: congestion, red hepatization, gray hepatization, resolution
- Most common cause overall is Streptococcus pneumoniae
- Klebsiella pneumoniae classically causes lobar pneumonia with currant-jelly sputum in alcoholics
- Air bronchograms on CXR distinguish consolidation from atelectasis
- Spread is via pores of Kohn within a lobe, not along airways (unlike bronchopneumonia)
- Egophony and increased tactile fremitus indicate underlying consolidation
- CURB-65/PSI scores guide admission decisions
- Rust-colored sputum is a classic but not universal pneumococcal finding
Etiology and risk factors
Streptococcus pneumoniae is the classic and most common cause of lobar pneumonia. Other organisms can produce a lobar pattern, particularly:
- Klebsiella pneumoniae — classically in alcoholics and diabetics, producing thick, blood-tinged ("currant jelly") sputum
- Legionella pneumophila — associated with water sources, GI symptoms, hyponatremia
- Haemophilus influenzae — in COPD patients and the unvaccinated
- Staphylococcus aureus — post-influenza, in IV drug users
- Mycobacterium tuberculosis — can mimic lobar consolidation, especially upper lobe
Risk factors
- Smoking and chronic alcohol use
- Age extremes (young children, elderly)
- Chronic lung disease (COPD, bronchiectasis)
- Immunosuppression (HIV, diabetes, splenectomy/asplenia, chemotherapy)
- Recent viral respiratory infection (influenza predisposes to secondary bacterial pneumonia)
- Aspiration risk (altered consciousness, dysphagia, poor dentition)
- Lack of pneumococcal or influenza vaccination
- Institutional living (nursing homes, close-contact settings)
Pathophysiology
Lobar pneumonia classically progresses through four pathologic stages, a frequently tested sequence:
| Stage | Timing | Findings |
|---|---|---|
| Congestion | Day 1-2 | Vascular engorgement, proteinaceous exudate, few neutrophils, organisms present |
| Red hepatization | Day 2-4 | Alveoli fill with neutrophils, red cells, fibrin; lung looks and feels liver-like, red and firm |
| Gray hepatization | Day 4-6 | Red cells degrade, fibrinopurulent exudate persists; lung turns gray-brown, still firm |
| Resolution | Day 8 onward | Macrophages digest exudate; it is enzymatically resorbed or coughed up; normal architecture restored |
Because spread occurs through intra-alveolar connections (pores of Kohn) rather than along airways, the entire lobe becomes uniformly involved while the airways themselves remain relatively patent, which explains the preserved air bronchogram sign on imaging. Pleural involvement overlying the consolidated lobe produces pleuritic chest pain and can progress to parapneumonic effusion or empyema.
Clinical features
Onset is typically acute, over hours to a day or two.
- High fever, often with rigors/chills
- Productive cough, classically with rust-colored or blood-tinged sputum (pneumococcal)
- Pleuritic chest pain, worse with deep inspiration or coughing
- Dyspnea and tachypnea
- Tachycardia
Exam findings over the consolidated lobe
- Dullness to percussion
- Increased tactile fremitus
- Bronchial breath sounds, late inspiratory crackles
- Egophony ("E to A" change)
- Whispered pectoriloquy
Elderly patients may present atypically with confusion, falls, or minimal fever rather than classic findings — a commonly tested pitfall.
Diagnosis
Diagnosis combines clinical findings with imaging and selected labs.
Imaging
- Chest X-ray (PA/lateral): homogeneous opacification confined to one lobe or segment, sharply marginated by a fissure, with air bronchograms; this is the single best initial confirmatory test
- CT chest: reserved for atypical presentations, suspected complications, or when X-ray is equivocal
Laboratory and microbiologic workup
- CBC: leukocytosis with neutrophilic predominance
- Blood cultures (recommended for hospitalized/severe CAP before antibiotics)
- Sputum Gram stain and culture
- Urinary antigen tests for S. pneumoniae and Legionella in moderate-to-severe cases
- Procalcitonin may support bacterial etiology but is adjunctive, not diagnostic alone
- Pulse oximetry/ABG to assess hypoxemia and need for admission
Severity assessment
Validated scores (CURB-65, Pneumonia Severity Index) guide the decision between outpatient treatment, ward admission, and ICU-level care, and are commonly tested for site-of-care decisions.
Differential diagnosis
- Bronchopneumonia — patchy, multifocal, airway-centered rather than lobar
- Pulmonary tuberculosis — subacute course, upper lobe cavitation, systemic symptoms
- Pulmonary infarction (PE) — pleuritic pain, hemoptysis, but typically wedge-shaped and afebrile initially
- Lung abscess — cavitation with air-fluid level, more indolent course
- Atelectasis — volume loss rather than true consolidation, no air bronchograms with mucus plugging
- Bronchogenic carcinoma with post-obstructive pneumonia — consider in older smokers with recurrent pneumonia in the same lobe
- Pulmonary edema — usually bilateral, cardiac history, no fever
Management
Management follows CAP guidelines (IDSA/ATS in the US; similar principles in ERS/ESCMID and other national guidelines, which may differ slightly on specific agents and durations).
Outpatient, previously healthy, no comorbidities
- Amoxicillin (preferred) or a macrolide/doxycycline in areas with low pneumococcal macrolide resistance
Outpatient with comorbidities (or recent antibiotics)
- Combination of a beta-lactam plus a macrolide, or monotherapy with a respiratory fluoroquinolone
Inpatient, non-ICU
- Beta-lactam (e.g., ceftriaxone) plus a macrolide, or a respiratory fluoroquinolone alone
Inpatient, ICU/severe CAP
- Beta-lactam plus either a macrolide or a fluoroquinolone; add coverage for Pseudomonas or MRSA if risk factors present
Supportive care
- Oxygen supplementation for hypoxemia
- Antipyretics/analgesics for fever and pleuritic pain
- Fluid management, mobilization, and treatment of underlying comorbidities
- Smoking cessation counseling
Prevention
- Pneumococcal conjugate and polysaccharide vaccines in eligible children, adults 65+, and high-risk groups
- Annual influenza vaccination to reduce risk of secondary bacterial pneumonia
Most patients improve clinically within 48-72 hours of appropriate therapy; lack of improvement should prompt reassessment for complications, resistant organisms, or an alternative diagnosis.
Complications and prognosis
- Parapneumonic effusion and empyema
- Lung abscess
- Bacteremia and sepsis
- Respiratory failure requiring mechanical ventilation
- Rarely, necrotizing pneumonia
Prognosis is generally favorable in healthy adults with prompt antibiotic therapy, with radiographic resolution often lagging clinical improvement by several weeks. Prognosis worsens with advanced age, multilobar involvement, bacteremia, and comorbid cardiopulmonary or immunocompromising conditions; these factors are incorporated into severity scoring systems used to guide site of care.
Stages of lobar pneumonia - "Can Red Grapes Resolve?": Congestion, Red hepatization, Gray hepatization, Resolution.
Practice questions
1. A 45-year-old man with a history of heavy alcohol use presents with 2 days of high fever, chills, and cough productive of thick, blood-tinged sputum. Chest X-ray shows dense consolidation of the right upper lobe with a bulging fissure. Which organism is most likely responsible?
2. A lung biopsy from a patient who died on illness day 4 shows alveoli filled with neutrophils, fibrin, and red blood cells, with the lung parenchyma appearing red, firm, and liver-like on gross examination. Which stage of lobar pneumonia does this represent?
3. A 68-year-old woman is admitted with lobar pneumonia. CURB-65 score is calculated to guide site-of-care decision. Which of the following is NOT a component of the CURB-65 score?
Frequently asked questions
What causes lobar pneumonia?
Streptococcus pneumoniae is the most common cause of lobar pneumonia. Other bacteria such as Klebsiella pneumoniae, Haemophilus influenzae, Legionella pneumophila, and Staphylococcus aureus can also produce this consolidation pattern, often in patients with specific risk factors like alcoholism, diabetes, recent influenza, or chronic lung disease.
What are the first symptoms of lobar pneumonia?
The earliest symptoms are usually sudden high fever with chills, a productive cough, and pleuritic chest pain that worsens with deep breaths or coughing. Shortness of breath and fast breathing often follow within hours to a day as the consolidation develops, and sputum may become rust-colored in pneumococcal disease.
How is lobar pneumonia diagnosed?
Diagnosis is based on clinical findings (fever, focal crackles, dullness to percussion) confirmed by chest X-ray showing dense consolidation limited to one lobe with air bronchograms. Blood cultures, sputum culture, and urinary antigen tests help identify the causative organism, especially in patients sick enough to require hospitalization.
Is lobar pneumonia curable?
Yes, lobar pneumonia is generally curable with timely, appropriate antibiotic therapy, and most otherwise healthy adults recover fully within one to two weeks clinically, though the chest X-ray may take several weeks longer to clear completely. Outcomes are worse in elderly or immunocompromised patients or when complications like empyema develop.
Lobar pneumonia vs bronchopneumonia — what is the difference?
Lobar pneumonia produces uniform, dense consolidation of an entire lobe spread through alveolar connections, most classically from Streptococcus pneumoniae. Bronchopneumonia produces patchy, multifocal infiltrates centered around bronchioles, often from mixed or hospital-acquired organisms, and is more common at the extremes of age.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: J18.1
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.